HomeCompareVNUE vs MRK

VNUE vs MRK: Dividend Comparison 2026

VNUE yields 13333.33% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VNUE wins by $944051876715324800.00M in total portfolio value
10 years
VNUE
VNUE
● Live price
13333.33%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$944051876715324800.00M
Annual income
$930,326,183,604,330,300,000,000.00
Full VNUE calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VNUE vs MRK

📍 VNUE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVNUEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VNUE + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VNUE pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VNUE
Annual income on $10K today (after 15% tax)
$1,133,333.33/yr
After 10yr DRIP, annual income (after tax)
$790,777,256,063,680,700,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, VNUE beats the other by $790,777,256,063,680,700,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VNUE + MRK for your $10,000?

VNUE: 50%MRK: 50%
100% MRK50/50100% VNUE
Portfolio after 10yr
$472025938357662400.00M
Annual income
$465,163,091,802,165,140,000,000.00/yr
Blended yield
98.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VNUE
No analyst data
Altman Z
-1856.1
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VNUE buys
0
MRK buys
0
No recent congressional trades found for VNUE or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVNUEMRK
Forward yield13333.33%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$944051876715324800.00M$56.8K
Annual income after 10y$930,326,183,604,330,300,000,000.00$9,798.13
Total dividends collected$943142383073684224.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VNUE vs MRK ($10,000, DRIP)

YearVNUE PortfolioVNUE Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,344,033$1,333,333.33$11,206$366.19+$1.33MVNUE
2$168,918,905$167,480,789.20$12,650$502.35+$168.91MVNUE
3$19,852,785,021$19,672,041,793.12$14,407$694.19+$19852.77MVNUE
4$2,182,013,981,744$2,160,771,501,770.83$16,585$967.82+$2182013.97MVNUE
5$224,287,824,199,531$221,953,069,239,064.90$19,342$1,363.89+$224287824.18MVNUE
6$21,561,870,489,323,890$21,321,882,517,430,390.00$22,913$1,947.19+$21561870489.30MVNUE
7$1,938,749,165,623,537,400$1,915,677,964,199,961,300.00$27,662$2,823.89+$1938749165623.51MVNUE
8$163,055,200,603,353,700,000$160,980,738,996,136,500,000.00$34,159$4,173.35+$163055200603353.69MVNUE
9$12,827,750,571,022,997,000,000$12,653,281,506,377,408,000,000.00$43,337$6,308.80+$12827750571022998.00MVNUE
10$944,051,876,715,324,800,000,000$930,326,183,604,330,300,000,000.00$56,776$9,798.13+$944051876715324800.00MVNUE

VNUE vs MRK: Complete Analysis 2026

VNUEStock

VNUE, Inc. operates as a music technology company. The company provides a suite of products and services that monetize and monitor music for artists, labels, performing rights organizations, radio stations, venues, restaurants, gyms, bars, and other businesses. It offers Set.fm/DiscLive Network, a digital live music distribution consumer app platform that allows users to download and purchase through their mobile devices; and provides physical collectible products that are recorded and sold at shows, as well as online through the company's partner DiscLive Network. The company also provides Soundstr, a music identification and rights management cloud platform that track and audit public performances of music; and offers collectible products, such as CDs, USB drives, and laminates. VNUE, Inc. was founded in 2013 and is based in New York, New York.

Full VNUE Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VNUE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VNUE vs SCHDVNUE vs JEPIVNUE vs OVNUE vs KOVNUE vs MAINVNUE vs JNJVNUE vs ABBVVNUE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.